OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oral Janus kinase inhibitors for atopic dermatitis
Daniela Mikhaylov, Benjamin Ungar, Yael Renert‐Yuval, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 5, pp. 577-592
Open Access | Times Cited: 35
Daniela Mikhaylov, Benjamin Ungar, Yael Renert‐Yuval, et al.
Annals of Allergy Asthma & Immunology (2023) Vol. 130, Iss. 5, pp. 577-592
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 202
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 202
Atopic dermatitis
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Emma Guttman‐Yassky, Yael Renert‐Yuval, Patrick M. Brunner
The Lancet (2025) Vol. 405, Iss. 10478, pp. 583-596
Closed Access | Times Cited: 3
Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv19454-adv19454
Open Access | Times Cited: 13
Esmé Kamphuis, Celeste M. Boesjes, Laura Loman, et al.
Acta Dermato Venereologica (2024) Vol. 104, pp. adv19454-adv19454
Open Access | Times Cited: 13
The role of the environment in allergic skin disease
Khushnood Faraz, Mason Seely, Anne L. Marano
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 6, pp. 323-330
Closed Access | Times Cited: 9
Khushnood Faraz, Mason Seely, Anne L. Marano
Current Allergy and Asthma Reports (2024) Vol. 24, Iss. 6, pp. 323-330
Closed Access | Times Cited: 9
An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 587-587
Open Access | Times Cited: 8
Kaviyon Sadrolashrafi, Lily Guo, Robin Kikuchi, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 587-587
Open Access | Times Cited: 8
TH2-driven manifestations of inborn errors of immunity
Alyssa James, Manar Abdalgani, Paneez Khoury, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 2, pp. 245-254
Closed Access | Times Cited: 8
Alyssa James, Manar Abdalgani, Paneez Khoury, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 2, pp. 245-254
Closed Access | Times Cited: 8
A New Horizon for Atopic Dermatitis Treatments: JAK Inhibitors
Mircea Tampa, Cristina Iulia Mitran, Mădălina Irina Mitran, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 19
Mircea Tampa, Cristina Iulia Mitran, Mădălina Irina Mitran, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 3, pp. 384-384
Open Access | Times Cited: 19
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2)
Jonathan I. Silverberg, Melinda Gooderham, Amy S. Paller, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 485-496
Open Access | Times Cited: 6
Jonathan I. Silverberg, Melinda Gooderham, Amy S. Paller, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 3, pp. 485-496
Open Access | Times Cited: 6
Efficacy of dupilumab with concomitant topical calcineurin inhibitors treatment for preschool children with atopic dermatitis: a retrospective cohort study
Liming Wu, Kamran Ali
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Liming Wu, Kamran Ali
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
N-Heterocyclic functionalized chalcone derivatives as anti-inflammatory agents for atopic dermatitis treatment by inhibiting JAK1/STAT3 signaling pathway
Zhengxiao Huang, Xinjia Zhang, Jing Li, et al.
Bioorganic Chemistry (2025), pp. 108200-108200
Closed Access
Zhengxiao Huang, Xinjia Zhang, Jing Li, et al.
Bioorganic Chemistry (2025), pp. 108200-108200
Closed Access
Type 2 Inflammation and Its Role in Dermatologic Diseases
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Raj Chovatiya, Jason E. Hawkes, Douglas DiRuggiero, et al.
International Journal of Dermatology (2025)
Open Access
Multidimensional Burden of Moderate-to-Severe Atopic Dermatitis in Adolescent and Adult Patients from Portugal and Greece: Results from the Global Cross-Sectional Study MEASURE-AD
Pedro Mendes‐Bastos, Elizabeth Lazaridou, Tiago Torres, et al.
Dermatology and Therapy (2025)
Open Access
Pedro Mendes‐Bastos, Elizabeth Lazaridou, Tiago Torres, et al.
Dermatology and Therapy (2025)
Open Access
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Skin infections during dupilumab monotherapy in moderate-to-severe atopic dermatitis – a meta-analysis of randomized clinical trials
Monika Marko, Rafał Pawliczak
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 1, pp. 121-134
Closed Access | Times Cited: 7
Monika Marko, Rafał Pawliczak
Expert Review of Clinical Immunology (2023) Vol. 20, Iss. 1, pp. 121-134
Closed Access | Times Cited: 7
Exploring the Complexities of Atopic Dermatitis: Pathophysiological Mechanisms and Therapeutic Approaches
Fihr Chaudhary, W. Lee, Tony Escander, et al.
Journal of Biotechnology and Biomedicine (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 2
Fihr Chaudhary, W. Lee, Tony Escander, et al.
Journal of Biotechnology and Biomedicine (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 2
Neutrophils in Atopic Dermatitis
Chih-Chao Chiang, Wei-Jen Cheng, Joseph Renz Marion Santiago Dela Cruz, et al.
Clinical Reviews in Allergy & Immunology (2024)
Open Access | Times Cited: 2
Chih-Chao Chiang, Wei-Jen Cheng, Joseph Renz Marion Santiago Dela Cruz, et al.
Clinical Reviews in Allergy & Immunology (2024)
Open Access | Times Cited: 2
Topical ruxolitinib for facial blaschkitis in an adolescent
Diana Zarowin, Lauren Provini, Richard J. Antaya
Pediatric Dermatology (2024) Vol. 41, Iss. 5, pp. 938-939
Closed Access | Times Cited: 1
Diana Zarowin, Lauren Provini, Richard J. Antaya
Pediatric Dermatology (2024) Vol. 41, Iss. 5, pp. 938-939
Closed Access | Times Cited: 1
Therapeutic management of atopic dermatitis
Lynda Jarrell
The Nurse Practitioner (2024) Vol. 49, Iss. 6, pp. 39-46
Closed Access | Times Cited: 1
Lynda Jarrell
The Nurse Practitioner (2024) Vol. 49, Iss. 6, pp. 39-46
Closed Access | Times Cited: 1
Race science without racists: how bigoted paradigms persist in allergy research
Ian A. Myles
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
Ian A. Myles
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 1
CCR8/CCL1 and CXCR3/CXCL10 axis mediated memory T cell activations in recalcitrant drug-induced hypersensitivity patients
Tsu‐Man Chiu, Chun‐Bing Chen, Chun‐Wei Lu, et al.
British Journal of Dermatology (2024)
Open Access | Times Cited: 1
Tsu‐Man Chiu, Chun‐Bing Chen, Chun‐Wei Lu, et al.
British Journal of Dermatology (2024)
Open Access | Times Cited: 1
Inhibidores de JAK en dermatitis atópica, nuevas perspectivas
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
[Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
Upadacitinib Is a Better Choice than Abrocitinib for Patients with Moderate-to-Severe Atopic Dermatitis: An Updated Meta-Analysis
Ying Zhang, Hong Pan, Saroj Rai, et al.
Journal of Clinical Pharmacy and Therapeutics (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 2
Ying Zhang, Hong Pan, Saroj Rai, et al.
Journal of Clinical Pharmacy and Therapeutics (2023) Vol. 2023, pp. 1-11
Open Access | Times Cited: 2
Not just another klass (JAK) of inhibitors for allergies
Wesley H. Brooks, Yves Renaudineau
Deleted Journal (2024) Vol. 1, pp. 100001-100001
Open Access
Wesley H. Brooks, Yves Renaudineau
Deleted Journal (2024) Vol. 1, pp. 100001-100001
Open Access
Pharmacokinetic Profile of Brepocitinib with Topical Administration in Atopic Dermatitis and Psoriasis Populations: Strategy to Inform Clinical Trial Design in Adult and Pediatric Populations
Farzaneh Maleki, Cheng Chang, Vivek S. Purohit, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 4, pp. 623-636
Open Access
Farzaneh Maleki, Cheng Chang, Vivek S. Purohit, et al.
Pharmaceutical Research (2024) Vol. 41, Iss. 4, pp. 623-636
Open Access
